Skip to content

Providing diagnostic accuracy in acute onset, continuous dizziness.

Providing diagnostic accuracy in acute onset, continuous dizziness. - PROVIDE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52153
Enrollment
800
Registered
2021-05-06
Start date
2021-08-18
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral infarction. Acute Vestibular Syndrome. Stroke

Interventions

None listed

Sponsors

Haaglanden Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Acute onset, continuous dizziness, still present at arrival on the ED as the principal reason for the ED visit. - Presentation within 24 hours after onset of dizziness. - Age 18 years or older. - For substudy 1: Presentation at the ED of one of the following centers: Haaglanden Medical Center, Haga Hospital, Jeroen Bosch Hospital or Gelre Hospital. - For substudy 1: Early MRI DWI

Exclusion criteria

Exclusion criteria: - Clear signs of benign paroxysmal positional vertigo (BPPV) (i.e. acute onset, continuous dizziness successfully treated by canalith repositioning). - Recognizable recurrent vertigo or acute onset dizziness compatible with a known previous diagnosis of Meniere*s disease or vestibular migraine; - New deficits upon neurological examination (i.e. ataxia, dysarthria, spontaneous skew deviation, gaze palsy or lowered state of consciousness (i.e. Glasgow Coma Scale (GCS) score

Design outcomes

Primary

MeasureTime frame
Primary endpoint is final diagnosis by the expert panel after three months.

Secondary

MeasureTime frame
Secondary endpoints are health care costs, sensitivity/specificity of early (72 hours and

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)